A Phase IIIb Study Comparing Two Boosted Protease Inhibitor-based HAART Regimens in HIV-infected Patients Experiencing Their First Virologic Failure While Receiving an NNRTI-containing HAART Regimen

PHASE3CompletedINTERVENTIONAL
Enrollment

200

Participants

Timeline

Start Date

May 31, 2004

Primary Completion Date

February 28, 2006

Study Completion Date

February 28, 2006

Conditions
HIV Infections
Interventions
DRUG

Atazanavir+ritonavir

Capsules, Oral, 300mg/100mg, once daily, 24 weeks.

DRUG

Lopinavir+ritonavir

Capsules, Oral, 800mg/200mg, twice daily, 24 weeks.

Trial Locations (53)

Unknown

Local Institution, Hobson City

Local Institution, Montgomery

Local Institution, Phoenix

Local Institution, Little Rock

Local Institution, Bakersfield

Local Institution, Los Angeles

Local Institution, San Francisco

Local Institution, San Mateo

Local Institution, Tarzana

Local Institution, West Hollywood

Local Institution, Norwalk

Local Institution, Washington D.C.

Local Institution, Atlantis

Local Institution, Fort Lauderdale

Local Institution, Jacksonville

Local Institution, Miami

Local Institution, Miami Beach

Local Institution, North Miami

Local Institution, Orlando

Local Institution, Plantation

Local Institution, Safety Harbor

Local Institution, Tampa

Local Institution, Atlanta

Local Institution, Decatur

Local Institution, Chicago

Local Institution, Indianapolis

Local Institution, Louisville

Local Institution, New Orleans

Local Institution, Boston

Local Institution, Springfield

Local Institution, Berkley

Local Institution, Jackson

Local Institution, St Louis

Local Institution, Las Vegas

Local Institution, East Orange

Local Institution, Hillsborough

Local Institution, Jersey City

Local Institution, Brooklyn

Local Institution, Mount Vernon

Local Institution, New York

Local Institution, Valhalla

Local Institution, Greenville

Local Institution, Huntersville

Local Institution, Winston-Salem

Local Institution, Oklahoma City

Local Institution, Philadelphia

Local Institution, Columbia

Local Institution, Dallas

Local Institution, Galveston

Local Institution, Harlingen

Local Institution, Houston

Local Institution, Hampton

Local Institution, Santruce

Sponsors
All Listed Sponsors
lead

Bristol-Myers Squibb

INDUSTRY